Nitric Oxide Synthase Enzymes in the Airways of Mice Exposed to Ovalbumin: NOS2 Expression Is NOS3 Dependent by Bratt, Jennifer M. et al.
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2010, Article ID 321061, 15 pages
doi:10.1155/2010/321061
Research Article
NitricOxide Synthase Enzymesin the Airwaysof Mice Exposedto
Ovalbumin:NOS2 Expression Is NOS3 Dependent
Jennifer M. Bratt, Keisha Williams, Michelle F. Rabowsky, Michael S. Last, Lisa M. Franzi,
Jerold A. Last, andNicholas J. Kenyon
Pulmonary and Critical Care Medicine, School of Medicine, Genome and Biomedical Sciences Facility, Suite 6500, 451 Health Sciences
Dr., University of California, Davis, CA 95616, USA
Correspondence should be addressed to Nicholas J. Kenyon, njkenyon@ucdavis.edu
Received 17 February 2010; Revised 29 June 2010; Accepted 2 August 2010
Academic Editor: Jan van Amsterdam
Copyright © 2010 Jennifer M. Bratt et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objectives and Design. The function of the airway nitric oxide synthase (NOS) isoforms and the lung cell types responsible for its
production are not fully understood. We hypothesized that NO homeostasis in the airway is important to control inﬂammation,
which requires upregulation, of NOS2 protein expression by an NOS3-dependent mechanism. Materials or Subjects.M i c ef r o ma
C57BL/6 wild-type, NOS1−/−, NOS2−/−, and NOS3−/− genotypes were used. All mice strains were systemically sensitized and
exposed to ﬁltered air or ovalbumin (OVA) aerosol for two weeks to create a subchronic model of allergen-induced airway
inﬂammation. Methods. We measured lung function, lung lavage inﬂammatory and airway epithelial goblet cell count, exhaled
NO, nitrate and nitrite concentration, and airway NOS1, NOS2, and NOS3 protein content. Results. Deletion of NOS1 or NOS3
increases NOS2 protein present in the airway epithelium and smooth muscle of air-exposed animals. Exposure to allergen
signiﬁcantly reduced the expression of NOS2 protein in the airway epithelium and smooth muscle of the NOS3−/− strain only.
This reduction in NOS2 expression was not due to the replacement of epithelial cells with goblet cells as remaining epithelial
cells did not express NOS2. NOS1−/− animals had signiﬁcantly reduced goblet cell metaplasia compared to C57Bl/6 wt, NOS2−/−,
and NOS3−/− allergen-exposed mice. Conclusion. The airway epithelial and smooth muscle cells maintain a stable airway NO
concentration under noninﬂammatory conditions. This “homeostatic” mechanism is unable to distinguish between NOS derived
from the diﬀerent constitutive NOS isoforms. NOS3 is essential for the expression of NOS2 under inﬂammatory conditions, while
NOS1 expression contributes to allergen-induced goblet cell metaplasia.
1.Introduction
Nitric oxide (NO) plays multiple roles in the lung in both
injury and repair; it is an airway and vascular smooth
muscle cell signaling molecule, an inhibitory nonadrenergic
noncholinergic (iNANC) signaling molecule, a modulator of
apoptosis, and a component of the bactericidal arsenal of
lung inﬂammatory cells. The primary molecular sources of
NO are the NOS enzymes, including the inducible NOS2
isoform, which is upregulated in the ovalbumin- (OVA-
) induced allergic airway inﬂammation model [1–3]a n d
the constitutively expressed NOS1 (neuronal NOS) and
NOS3 (endothelial NOS) isoforms, which contribute to the
generation of NO in the murine airway epithelium [4,
5]. NO can be further metabolized to produce the more
stable products, nitrate and nitrite. Both of these products
are considered bioactive, capable of enzyme-dependent and
enzyme-independent reconversion into NO [6, 7].
Inasthma,increasedNOconcentrationinexhaledbreath
isconsideredadiseasebiomarkerandissupportedbycurrent
guidelines for use in clinical settings [8]. The conventional
treatment of asthmatics using inhaled steroids decreases
exhaled NO [9], but whether alleviation of the asthmatic
symptoms is a result of decreasing exhaled NO or if the
decreased exhaled NO is a byproduct of decreasing overall
lung inﬂammation is still debated.
In the cell, maintenance of a stable NO concentration,
or NO homeostasis, is essential, as ﬂuctuations in the con-
centration of NO can alter intra and intercellular signaling
and aﬀect survivability. NO homeostasis, therefore, appears2 Mediators of Inﬂammation
tobetightlyregulated.Cooketal.[10],forexample,detected
an increase in the concentration of NO in exhaled breath
correlating to an increase in NOS2 expression in NOS3−/−
mice, thus indicating a compensatory mechanism for the
regulation of baseline NO production. Also, exposure of
astrocytes to NO-scavenging hemoglobin increased NOS2
expression and was dependent on NF-κBa c t i v a t i o n[ 11].
In addition to maintaining a baseline of NO production,
it is necessary to upregulate NO production under speciﬁc
conditions such as during oxidative stress [12], release of
heme-containing compounds [13, 14], or the launching of
an inﬂammatory response [15]. Thus, the ability to further
regulate NOS2 expression in constitutive NOS isoform
knockout strains may be necessary for the organism to
modulate its reaction to an insult and also resolve the
response. A study by Connelly et al. [16], using LPS stim-
ulation, determined that NF-κB translocation was necessary
forNOS2expressionunderinﬂammatoryconditionsandthe
study by Gobeil Jr. et al. identiﬁed NOS3 nuclearization as
essential for NF-κB activation leading to NOS2 expression
[17].
We previously identiﬁed NOS2−/− mice as being more
susceptible to severe allergic inﬂammation and subepithelial
ﬁbrosis than their C57Bl/6 wild-type counterparts [1] indi-
cating that NOS2 expression and activity are necessary for
regulating the intensity of the inﬂammatory response. Thus,
we chose to examine NO homeostatic dysregulation in the
development of allergic airway disease.
In this paper, we hypothesized that under normal con-
ditions, deleting the NOS1 or NOS3 gene would upregulate
NOS2 protein expression. Thus, the lung function and total
cellular population of ﬁltered air-exposed NOS1−/− and
NOS3−/− mice should be comparable to ﬁltered air-exposed
C57Bl/6 wt mice, while the NOS2−/− mice should have
a heightened inﬂammatory cell proﬁle as observed in our
previousstudy[18].Furthermore,TenBroekeandcolleagues
showed that NOS2 expression was NOS3 dependent, and we
therefore hypothesized that exposure of mice to ovalbumin
(OVA) would inhibit this increase in NOS2 protein expres-
sion in the NOS3−/− mice resulting in lower NOS2 protein
concentrations compared to NOS3−/− ﬁltered air controls
[19].Wealsohypothesizedthatthiswouldresultinincreased
lung inﬂammation in the NOS3−/− mice compared to both
OVA-exposed C57Bl/6 wt and NOS1−/− mice. To this end,
we performed lung function analysis with a methacholine
challenge protocol and collected bronchoalveolar lavage
for the calculation of lung inﬂammatory cell inﬂux and
inﬂammatory cell proﬁle. We also examined tissue-speciﬁc
NOS2 expression patterns in the lungs and changes in
nitric oxide production of both ﬁltered air-exposed and
OVA-exposed mice from NOS1−/−,N O S 2 −/−,N O S 3 −/−,a n d
C57Bl/6 wt genotype.
2. ExperimentalMethods
2.1. Animals. A l lp r o c e d u r e sw e r ep e r f o r m e da sp e ro u r
IACUC-approved protocol, following their standards and
regulations.AllanimalsweremaintainedinanHEPA-ﬁltered
laminar ﬂow cage rack with a 12-hour light/dark cycle and
allowed free access to food and water. Animals were housed
and cared for by the veterinary staﬀ of Animal Resource
Services at UCD in AALAC- accredited facilities, in plastic
cages over autoclaved bedding in HEPA-ﬁltered cage racks.
Animalswereroutinelyscreenedforhealthstatusbyserology
and histology by our veterinary animal resources facility.
NOS1−/−,N O S 3 −/−, and the wild type strain C57BL/6 mice
were purchased from Jackson Laboratories. The NOS2−/−
mice were initially purchased from Taconic Laboratories,
G e r m a n t o w n ,N Ya n dw e r er e d e r i v e db ye m b r y ot r a n s f e r
to establish a breeding colony in the Targeted Genomics
LaboratoryoftheMouseBiologybarrierfacilityatUCDavis.
They are on a C57BL/6 background and are designated
C57BL/6Ai-[KO]NOS2 N5 [20].
2.2. Exposure of Mice to OVA Aerosol. Mice were sensitized
by intraperitoneal (ip) injection of chicken egg albumin
(Ovalbumin, grade V, ≥98% pure, Sigma, St. Louis, MO, 2×
10μg/0.1mL, 2 weeks apart) with alum as an adjuvant [21].
Exposure to OVA aerosols was performed using chambers
and generators we have described elsewhere [22]. Exposures
to OVA aerosol, 10mL of a 10mg/mL (1%) solution, were
begun on day 28. Mice were exposed for 30 minutes, three
times per week for the duration of a given experiment.
Age-matched control animals were injected ip with OVA
(sensitized) but were then exposed to ﬁltered air.
Histological evaluations of C57Bl/6 wt mice OVA-
exposed and ﬁltered air-exposed control mice demonstrated
that we were able to induce airway inﬂammation, epithelial
cell sloughing, and goblet cell hyperplasia in the exposed
mice.
2.3. Lung Compliance and Resistance Measurements. Dy-
namic compliance and resistance of the respiratory system
were measured using a plethysmograph for restrained ani-
mals. (Buxco Inc., Troy, NY). Mice were deeply anesthetized
and sedated with medetomidine, 0.5mg/kg (Domitor, Orion
Pharma, Finland), and tiletamine/zolpidem, 50mg/kg (Tela-
zol, Fort Dodge Laboratories, Fort Dodge, IA) and ven-
tilated at 7-8cc/kg with a mouse ventilator (MiniVent,
Harvard Apparatus, Cambridge, MA) for the duration of the
procedure. Compliance and resistance measurements were
made at baseline and immediately following serial 3-minute
nebulizations of saline and methacholine (0, 0.5, 1.0, and
2.0mg/mL).
2.4. Airway Inﬂammation. After the physiological mea-
surements, animals were euthanized with an overdose of
phenobarbital and dilantin administered via intraperitoneal
injection. Animals were placed on a restraining board and
their lungs lavaged with two 1mL aliquots of phosphate-
buﬀered saline (PBS), pH 7.4, and each aliquot was passaged
twice through the lungs. Cells were pelleted at 2500rpm
for 10 minutes, and the acellular supernatant was removed
and stored at −20◦C for nitrate and nitrite (NOx) analysis.
The remaining cell pellet was treated with a lysis buﬀerMediators of Inﬂammation 3
(0.15M NH4Cl, 1mM KHCO3,0 . 1m ME D T A ,a n dp H7 . 3 ) ,
repelleted, and resuspended in 0.5mL PBS.
Totallavagecellnumberwasdeterminedusingahemocy-
tometer and 100μL aliquots of the remaining cell suspension
processed onto slides using a cytocentrifuge at 1650rpm for
15 minutes. Slides were air dried and stained with a Hema3
stain set as described in the manufacturer’s instructions
(Biochemical Sciences, Swedesboro, NJ) and sealed using
Cytoseal (Stephens Scientiﬁc, Kalamazoo, MI). Cell percent
diﬀerentials were determined by counting 10 ﬁelds under a
40× objective. Cells were classiﬁed as alveolar macrophage,
neutrophil, eosinophil, lymphocyte, or other based upon
morphological characteristics and staining proﬁle.
2.5. Measurement of Exhaled NO and NOx Flux in Lung.
Five-minute samples of exhaled gases were collected into a
specially constructed Mylar bag from the cannulated mice
via the ventilator exhalation port immediately after insertion
of a mouse into the plethysmograph. This 5-minute sample
was adequate for the measurement of NO concentration
in the expired air, using a Sievers Nitric Oxide analyzer
(Sievers Inst., Boulder, CO) [23]. Nitrate and nitrite (NOx)
was measured in lavage ﬂuid with this analyzer as previously
described [24].
2.6. Western Blot Analysis of Tissue. Western blots were
performed as described by Bratt et al. 2009 with changes
indicated below. Antibodies were purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA) unless otherwise
stated.
The isolated airways were prepared by microdissecting
theleftlunglobetoobtainapreparationofthelargerairways
distal to the carina from the left bronchus through the third
generation of conducting airway, separate from adhering
parenchyma. The tissue was homogenized and processed
as described by Bratt et al. [18]. Samples containing 20μg
total protein were electroporated under reducing conditions
and transferred to a polyvinylidene diﬂuoride (PVDF)
membrane. Membranes were incubated in 0.6μg/mL rabbit
antimouse NOS1, 0.8μg/mL NOS2, 0.6μg/mL NOS3, or
0.4μg/mL α-Actinin IgG (used as a gell loading control)
in 5% dry milk in PBS overnight at 4◦C and incubated in
40ng/mL horseradish peroxidase- (HRP-) conjugated goat
antirabbit IgG (Pierce Biotechnology, Rockford, IL) in 5%
milkinPBS.BandswerevisualizedusingImmobilonwestern
chemiluminescent HRP substrate kit (Millipore, Billerica,
Massachusetts) and band intensity-assessed using the Kodak
1D version 3.5.4 scientiﬁc imaging system (Eastman Kodak
Co, CT).
2.7. Histological Preparation. Half of the animals had their
lungs ﬁxed for histological evaluation at 30cm pressure
using 1% paraformaldehyde in PBS (pH 7.5). After 24 hours
of ﬁxation, the left lung was placed in 70% ethanol and
embedded in paraﬃn. Lung sections of 5-um thickness were
made with special attention to cutting through the larger
lobar bronchi in parallel then dried at 37◦C overnight.
Lung sections were deparaﬃn i z e da n dp r o c e s s e df o r
hematoxylinandeosin(H&E)staining forevaluationoftotal
inﬂammation, or NOS2-speciﬁc immunohistochemistry for
semiquantitative assessment of tissue-speciﬁc NOS2 expres-
sion or Alcian Blue-Periodic Acid-Schiﬀ (PAS) staining for
quantitation of mucus-containing goblet cells.
2.8. NOS2 Immunohistochemistry. Left lung sections were
prepared as described. Slides were incubated in 1mM ETDA,
pH 7.5 at 100◦C for 20 minutes to decloak antigen. Sections
were processed using the R&D Systems Cell and tissue
staining kit HRP-DAB System (Minneapolis, MN) for rabbit
antibodies. Sections were incubated overnight at 4◦Ci n
0.2μg/mL rabbit anti-mouse NOS2 IgG diluted in 5% goat
serum in 1% BSA, 0.2μg/mL rabbit IgG (isotype control),
or serum + BSA only (negative control). All other reagents
were diluted as per manufacturer’s instructions. Incubation
times were as follows: 1 hour in biotinylated goat antirabbit
secondaryantibody,30minutesinHSS-conjugatedHRP,and
15 minutes in diaminobenzidine.
A blinded observer scored the results of the NOS2
immunohistochemical staining. A grading system of 0–10
was established prior to the grading based upon a series of
prestained slide standards. The lung tissue compartments
were divided into airway epithelium, smooth muscle, and
macrophages and were scored under 200X power. The linear
intensity grading scale used was 0—no NOS2 stain as
compared to a primary antibody negative control to 10—
dramatically increased NOS2 staining comparable to a lung
s e c t i o nf r o ma nL P S - t r e a t e dm o u s e .
2.9.AlcianBlue-PeriodicAcid-Schiﬀ(PAS)Staining. Leftlung
sections, prepared as described above, were immersed in a
1% alcian blue, 3% glacial acetic acid solution (pH2.5) for
30 minutes, rinsed in tap water, and then immersed in a 1%
periodic acid solution for 7 minutes. Slides were then rinsed
again in distilled water and immersed in Schiﬀ Reagent
Solution consisting in 0.45% basic fuchsin, 10% HCl, and
0.45% sodium bisulﬁte for 15 minutes. Slides were cleared in
runningtapwater,counterstainedusingHarris’hematoxylin,
and then dehydrated and mounted in cytoseal.
Each animal was represented by a single section of lung
selected for maximal visualization of the main airway. Each
section had 5 randomly selected regions evaluated (two
segments of the 1  conducting airway, two segments from
separate 2  conducting airways, and one segment from a 3 
conducting airway). A minimum of 100 sequential airway
epithelial cells were counted from each region and the total
number of PAS positive cells per total epithelial cells was
determined for each region. These regional values were then
averaged to give a ﬁnal PAS score per animal.
2.10. Statistical Analysis of Data. Results are presented as
mean values ± SEM. Means were compared by t-test or by
ANOVA, with Tukey’s correction for multiple comparisons
applied where appropriate. A P-value of .05 or less was
taken to indicate signiﬁcance. Analysis of the compliance
and resistance changes was done by both two-way ANOVA4 Mediators of Inﬂammation
with Bonferroni correction and by linear regression analysis,
using the Prism software package (Graphpad Prism 5.0,
San Diego, CA). We believe that the combination of these
methods allowed for better understanding of the interaction
between the eﬀect of OVA exposure and methacholine
aerosol challenge. R, a common open source statistical
computing package (URL: http://www.R-project.org), was
used to perform this analysis.
3. Results
3.1. Lung Inﬂammation in NOS Knockout Mice Exposed
to Ovalbumin. NOS2−/− mice exposed only to ﬁltered air
contained 8.65 ± 6.90 × 104 total cells per lavage sample
(Figure 1(a)), of which 92 ± 2% were pulmonary alveolar
macrophages, signiﬁcantly more total cells than were found
in the NOS1−/−,N O S 3 −/−, and C57BL/6 mouse strains
exposed only to ﬁltered air (P<. 01).
AftertwoweeksofOVAexposure,thetotalinﬂammatory
cell number recovered by lavage increased signiﬁcantly in all
strains of mice evaluated. NOS2−/− mice exposed to OVA
for two weeks had signiﬁcantly more lung lavage cells than
the NOS1−/−,N O S 3 −/−, or C57BL/6 mice exposed to OVA
(Figure 1(b), P<. 05).
The normal lung lavage from a healthy mouse contains
more than 90% alveolar macrophages, and our observations
in this study were consistent with this ﬁnding. There were
<1% eosinophils (88 ± 230 eosinophils) in all of the strains
of mice tested after exposure to ﬁltered air (Figure 1(c)).
NOS2−/− mice exposed to OVA had 11.90 ± 1.76 × 105
eosinophilsintheirlavageﬂuid,whichwassigniﬁcantlymore
than were observed in NOS1−/−,N O S 3 −/−, or C57BL/6 mice
exposed to OVA (P<. 01).
There was a small (<17,000 cells) but signiﬁcant increase
in the number of lymphocytes in all groups of OVA-
exposed mice compared to ﬁltered air-exposed mice (data
not shown), but no signiﬁcant diﬀerences between the four
diﬀerent strains exposed to OVA. In addition, the percentage
of neutrophils was <1% in all mouse strains exposed to
OVA. The rest of the cells in the lung lavage ﬂuid were
macrophages.
These results extend our previous ﬁnding that mice lack-
ing the inducible NOS2 gene are more susceptible to allergic
airway inﬂammation [1] than wild-type or constitutive NOS
knockout mice strains.
3.2. Exhaled NO and NOx Concentrations in NOS Knockout
Mice. To determine which NOS isoform is responsible for
the production of NO in the expired breath, we compared
the concentration of exhaled NO between C57Bl/6 mice and
the three NOS−/− mouse strains exposed to ﬁltered air. All
NOS−/− strains exposed to ﬁltered air had similar exhaled
NO concentrations (Figure 2(a)); NOS1−/− (5.1 ± 1.6ppb),
NOS2−/− (5.0±0.5ppb), and NOS3−/−mice (7.5±1.8ppb),
respectively.C57BL/6miceexhaledasigniﬁcantlygreaterNO
concentration than NOS2−/− animals (9.7 ±0.5v e r s u s5 .0 ±
0.5ppb,P<. 001).
After exposure for two weeks to OVA aerosol, there was
no signiﬁcant change in exhaled NO concentrations in any
of the knockout mice strains compared to their respec-
tive ﬁltered air-exposed groups (Figure 2(a)). However, the
NOS2−/− animals exposed to OVA had signiﬁcantly lower
NOconcentrationsinexhaledbreaththantheNOS3−/− mice
exposed to OVA (4.9 ± 0.5v e r s u s7 .7 ± 1.1ppb,resp.,P<
.05). In contrast, there was a decrease in exhaled NO in the
C57BL/6 mice exposed to OVA compared to their controls
exposedtoﬁlteredair(9.7±0.5v ersus7.2±0.6ppb,P<. 05).
Lung lavage NOx concentrations of ﬁltered air-exposed
mice (Figure 2(b)) from mice of all four strains were not sig-
niﬁcantly diﬀerent from each other. After exposure to OVA,
both NOS3−/− and C57Bl/6 mice had signiﬁcant increases
in NOx levels compared to their respective ﬁltered air
groups. C57BL/6 mice exposed to OVA also had signiﬁcantly
higher NOx levels compared to NOS1−/− and NOS2−/−
mice exposed to OVA. We examined whether NOS isoform
protein expression, NO levels in exhaled breath, or NOx
concentrations in bronchoalveolar lavage were correlated by
linear regression analysis. We found that exhaled NO levels
were lower in C57Bl/6 mice after exposure to ovalbumin
compared to their matched controls exposed only to ﬁltered
air. Interestingly, this result diﬀered distinctly from our
lung lavage NOx data. Total nitrate/nitrite, the more stable
products of NO metabolism, was increased in the C57Bl/6
mice exposed to ovalbumin. It is unclear to us why this
mightbeastrain-relatedresult.Thereisnoobviousreasonto
believe that NO consumption is greater in lungs of inﬂamed
wild type mice compared to others. Overall, we have some
evidence that total lung NO content was increased in the
mice after ovalbumin exposure.
There was no correlation between NOS2 protein expres-
sion in the isolated airways and exhaled NO in any of
the strains examined (data not shown). However, there
was a signiﬁcant correlation between NOS2 protein expres-
sion in the isolated airways and bronchoalveolar lavage
nitrate/nitrite concentration in the ﬁltered air and OVA-
treated groups of the NOS3−/− strain (band intensity versus
NOx concentration m = 18.02±6.17, r2 = 0.36, and P<. 05,
Figure 3). There were no signiﬁcant correlations between
NOx concentration and NOS protein expression in the other
mouse strains (data not shown).
3.3. Lung Physiology in NOS Knockout Mice. To measure
the development of airway hyperreactivity (AHR) in our
model, we compared the total lung resistance and dynamic
compliance at baseline and after inhalation of nebulized
methacholine using serial doses of methacholine (0.5, 1.0,
and 2.0mg/mL). Lung compliance decreased signiﬁcantly
in NOS2−/− mice exposed to OVA compared to ﬁltered air
(Figure 4(c)). The diﬀerence in lung compliance between
the air and OVA-exposed NOS2−/− mice was signiﬁcant
at each dose of methacholine (P<. 001 for 0–2.0mg/mL
methacholine). The slope of the MCh response by linear
regression analysis for NOS2−/− mice exposed to OVA
(−2.6 ± 0.27 × 10
−3, F = 96.35) was signiﬁcantly diﬀerent
from that of the NOS2−/− mice exposed to air (−1.8±0.12×Mediators of Inﬂammation 5
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Figure 2: Exhaled NO (a) and lung lavage NOx (b) concentrations in strains of mice exposed to ﬁltered air or 2 weeks of OVA. NOS2−/−
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versus 5.12 ± 4.2( n = 26)ppb, P = .02). Air-exposed NOS2−/− mice have lower exhaled NO levels compared to air-exposed C57Bl/6 mice
(5.10 ± 0.41 (n = 8) versus 9.1 ± 0.7( n = 8)ppb, P<. 001). Air-exposed NOS1−/− and NOS3−/− also had signiﬁcantly lower exhaled NO
levels compared to the C57Bl/6 mice (P<. 05). After exposure to OVA, there were no signiﬁcant increases in the exhaled NO levels in any
strain compared to their respective air-exposed group. C57Bl/6 mice exposed to OVA had a signiﬁcant decrease in exhaled NO compared
to their ﬁltered air controls in this experiment. In contrast, lung lavage NOx concentration (b) from NOS1−/− and NOS2−/− mice exposed
to OVA was signiﬁcantly less than C57Bl/6 mice exposed to OVA. Data are presented as means ± SEM. ∗ denotes P<. 05; ∗∗∗P<. 001 by
ANOVA.
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10
−3, F = 226.9; P<. 05). Measured lung compliance
after exposure to methacholine also signiﬁcantly diﬀered
for NOS3−/− mice exposed to OVA versus air (Figure 4(d)).
The slopes of the best ﬁt lines by linear regression analysis
for the methacholine dose-response curve for OVA-exposed
NOS3−/− mice, −0.5 ± 0.2 × 10
−3, F = 4.627, and for
ﬁltered air-exposed NOS3−/− mice was −3.0 ± 0.3 × 10,
F = 95.07 (P = .004).NeithertheC57BL/6northeNOS1−/−
mice demonstrated signiﬁcant decreases in lung compliance
with methacholine challenge after exposure to OVA (Figures
4(a) and 4(b)).
Lung resistance measurements from the four diﬀerent
strains of mice examined did not show signiﬁcant diﬀerences
when analyzed by two-way ANOVA (Figures 5(a)–5(d))
but diﬀered signiﬁcantly compared to their corresponding
ﬁltered air exposures when analyzed by linear regression
analysis. Upon challenge with increasing doses of MCh,
NOS1−/− mice exposed to OVA (slope = 0.266 ± 0.027, F =
94.09) had a signiﬁcantly greater increase in lung resistance
compared to the same strain of mice exposed to ﬁltered air
(slope = 0.079 ± 0.008, F = 93.15; P = .002). Air- and
OVA-exposed NOS2−/− mice had similar increases in lung
resistance upon MCh challenge testing (slopes = 0.12 ± 0.01
and0.15±0.02,resp.).Theseresultssuggestthatthesestrains
of mice behaved diﬀerently than the NOS1−/− or NOS3−/−
mice after their respective exposures, which could reﬂect
diﬀerences in their inﬂammatory responses, diﬀerences in
airway remodeling, or both factors.
3.4. NOS Protein Content in Airways Isolated from NOS
Knockout Mice. T h er e l a t i v ea m o u n to ft h ed i ﬀerent NOS
isoforms in airways isolated from each of the mouse strainsMediators of Inﬂammation 7
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Figure 4: Total lung compliance in (a) C57BL/6, (b) NOS1−/−, (c) NOS2−/−, and (d) NOS3−/− mice exposed to either ﬁltered air or 2 weeks
of OVA. Symbols: (blue) open triangles for ﬁltered air exposure, (black) circles for OVA exposure. Lung compliance was measured at baseline
and following serial doses (0, 0.5, 1.0, and 2.0mg/mL) of nebulized methacholine (MCh). The slope of the MCh response for NOS2−/− mice
exposed to OVA (−0.0028±0.00042,F = 43.56)wassigniﬁcantlydiﬀerentfromthatoftheNOS2−/− miceexposedtoair(−0.0003±0.00017,
F = 3.0; P = .005). For NOS3−/− mice, the slopes of the best ﬁt lines for the MCh response curve for OVA-exposed mice (−0.0005 ±0.0002,
F = 4.627) and ﬁltered air-exposed mice (−0.003 ± 0.0003, F = 95.07) were also diﬀerent (P = .004). NOS3−/− mice (both air and OVA
exposed) had signiﬁcantly lower lung compliance at baseline compared to all of the other strains and were most diﬀerent from the NOS1−/−
(Cdyn: 0.017 ± 0.002 (n = 12) versus 0.031 ± 0.0008 (n = 8)mL/cmH2O, resp., P<. 0001) and NOS2−/− (Cdyn: 0.017 ± 0.002 versus
0.029 ±0.0008 (n = 24)mL/cmH2O, resp., P = .0002).
was assessed using western blot band intensity analysis. Pro-
tein blots of airways from both the NOS1−/− (Figure 6(a))
and NOS3−/− (Figure 6(b)) mice exposed to ﬁltered air
showed a higher NOS2 protein expression than the C57Bl/6
controls (NOS1−/− 60.2 ± 10.7v e r s u sw tC 5 7B l / 66 .5 ± 3.6,
P<. 01) and (NOS3−/−95.6±28.1 versus wt C57 Bl/6 26.6±
5.1, P<. 05). Upon OVA exposure, the NOS2 expression
in NOS1−/− animals was further upregulated (96.5 ± 30.1
(OVA) versus 60.2 ± 10.7( F A ) ,P = .019), while NOS3−/−
animals (Figure 6(b)) showed no change in NOS2 with
OVA treatment compared to their ﬁltered air controls. In
contrast, the NOS2−/− mice (Figures 7(a) and 7(b)) showed
no signiﬁcant change in the protein levels of either NOS1 or
NOS3 in the airway samples from mice that were exposed to
ﬁltered air or OVA.
3.5. Tissue-Speciﬁc NOS2 Protein Content in NOS Knockout
Mice. Weanalyzedsmoothmuscletissue,airwayepithelium,
andmacrophagepopulationstoevaluatediﬀerencesinNOS2
protein content between these three lung tissue compart-
ments. Consistent with the western blot data derived from
theisolatedairways,NOS1−/− andNOS3−/− miceexposedto
ﬁltered air had a greater NOS2 protein content than C57Bl/6
mice exposed to ﬁltered air (Figures 8 and 9). Quantitative
assessment by immunohistochemistry of these air-exposed8 Mediators of Inﬂammation
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Figure 5: Total lung resistance in (a) C57BL/6, (b) NOS1−/−, (C) NOS2−/−, and (D) NOS3−/− mice exposed to either ﬁltered air or 2 weeks
of OVA. Symbols: (blue) open triangles for ﬁltered air exposure, (black) circles for OVA exposure. Lung resistance was measured at baseline
and following serial doses (0.5–2.0mg/mL) of nebulized methacholine. NOS1−/− mice exposed to OVA (slope = 0.266 ± 0.027, F = 94.09)
had a signiﬁcantly greater increase in lung resistance compared to the same strain of mice exposed to ﬁltered air (slope = 0.079 ± 0.008,
F = 93.15; P = .002). Air- and OVA-exposed NOS2−/− mice had similar increases in lung resistance (slopes = 0.12 ± 0.01 and .015 ± 0.02,
resp.), but their intercepts were signiﬁcantly diﬀerent (y intercept 1.09 ±0.02 versus 1.3 ±.0.06, resp., P = .0001).
mice showed that increases in NOS2 protein content were
limited to the airway epithelium (NOS1−/− versus C57BL/6:
P<. 05 and NOS3−/− versus C57Bl/6: P<. 05) and the
smooth muscle of the airways and vasculature (NOS1−/−
versus C57BL/6: P<. 01 and NOS3−/− versus C57Bl/6: P<
.01), but no change in NOS2−/− content was detected in the
tissue macrophage population (Figure 9).
OVA exposure signiﬁcantly reduced total NOS2 protein
intheairwayepitheliumandsmoothmuscletissuecompared
to the ﬁltered air-exposed animals in the NOS3−/− mice
(Figures 9(a) and 9(b), P<. 01). In contrast to the
NOS3−/− mice exposed to OVA, the NOS1−/− mice exposed
to OVA maintained the NOS2 protein content in the airway
epithelium and also showed signiﬁcant increases in NOS2
protein content in the macrophage population (Figures 9(a)
and 9(c), P<. 05 compared to OVA-exposed NOS3−/− and
ﬁltered air-exposed NOS1−/− mice).
3.6. Goblet Cell Metaplasia in NOS Knockout Mice. To deter-
mine if the decrease in NOS2 protein content in the airway
epithelium was due to the replacement of ciliated epithelium
with mucus-producing goblet cells in the NOS3−/− animals
exposed to OVA, we used the Periodic Acid-Schiﬀ (PAS) to
stain for mucus-containing cells in the airway epithelium
anddeterminedtheoverallratioofmucus-containingcellstoMediators of Inﬂammation 9
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Figure 6: Relative band intensity of NOS2 protein by Western blot
in (a) NOS1−/− and (b) NOS3−/− mice. NOS1−/− animals showed
an upregulation of inducible NOS2 in air control animals and
maintained the pattern of NOS2 upregulation in response to OVA
treatment. NOS3−/−animals also showed a signiﬁcant upregulation
of NOS2 in ﬁltered air-exposed animals, but no change in NOS2 in
response to OVA treatment. Data are expressed as mean values ±
SEM (n = 4). ∗ denotes P<. 05; ∗∗P<. 01 by ANOVA.
total cell population by cell counting. All of the ﬁltered air-
exposed groups contained essentially no mucus-producing
cellsintheairways(see,e.g.,C57BL/6animals;Figure 10(a)).
In contrast, exposure to OVA signiﬁcantly increased the
number of mucus-containing cells in all three strains of
mice tested (Figures 10(b)–10(d)). We observed that 9–37%
of the total cell population of the upper airway epithelium
was mucus-producing cells, and that the observed value
depended on the genotype (Figure 11)w i t hN O S 1 −/− mice
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Figure 7: Relative band intensity of staining of (a) NOS1 protein
and (b) NOS3 protein by Western blot in NOS2−/− mice. No
signiﬁcantchangeisintheproteinlevelsofeitherNOS1orNOS3in
airways of mice exposed to ﬁltered air or OVA. Data are expressed
as mean values ± SEM (n = 4 each).
exposed to OVA having signiﬁcantly fewer PAS positive-
stained cells compared to the OVA-exposed C57Bl/6 (P<
.01) or NOS3−/− (P<. 05) mice.
4. Discussion
4.1. Anti-Inﬂammatory Role of NOS2 and Its Eﬀects on Lung
Function. NO modulates pulmonary vascular tone, non-
adrenergic non-cholinergic mediated bronchodilation, the
lung inﬂammatory response [25], and apoptosis [26–29].
In previous work using an NOS2−/− strain, we observed
increased airway inﬂammation as compared to wild-type
mice exposed only to air, and especially upon exposure to
OVA [1]. We concluded that the ability to upregulate active
NOS2 enzyme in response to OVA exposure is necessary10 Mediators of Inﬂammation
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Figure 8: Immunohistochemical stain of NOS2 protein in 5μm thick left lung sections from C57Bl/6 (a) ﬁltered air-exposed and (e) OVA-
exposed mice, NOS1−/− (b) ﬁltered air-exposed and (f) OVA-exposed mice, NOS2−/− (c) ﬁltered air-exposed mice, and NOS3−/− (d) ﬁltered
air-exposed and (g) OVA-exposed mice. Airway smooth muscle layer is indicated by arrow. Images were taken at 400× magniﬁcation.
for the anti-inﬂammatory eﬀect imparted by NO. However,
these earlier ﬁndings could not deﬁne the mechanistic basis
for these observations, for example, whether NOS2 was
itself the required source for NO in allergen-induced airway
inﬂammationorwhethertheeﬀectswerecausedbyincreased
L-arginine turnover by the other NOS isoforms or the
reconversionofoxidizationproducts,nitrateandnitrite,into
NO. To attempt to answer these questions, we examined the
eﬀects of deleting individual NOS isoforms on the overall
dynamic of total lung NO balance in allergic airway disease.
Measurements of exhaled NO in the various mouse
strains tested focused our attention on NOS2 as the most
likely source of NO in exhaled air from mice exposed
to ovalbumin (Figure 3). Examination of the correlation
between NOS2 protein expression in isolated airways and
total concentration of NOx in the lung lavage ﬂuid showed
that the NOS3−/− strain was the only strain studied,
where NOS2 protein expression was tightly coupled to
NOx production, and such coupling was observed in the
NOS3−/− mice exposed to either air or ovalbumin. Steudel
et al. [30] examined exhaled NO from NOS1−/−,N O S 2 −/−,
and NOS3−/− mice. The NOS2−/− mice showed decreased
exhaled breath NO as compared to control animals. In con-
trast, the NOS1−/− and NOS3−/− mice actually exhaled more
NO than their wild-type counterparts. The upregulation of
NOS2 we observed in the two constitutive NOS knockout
strains may explain this ﬁnding.
In previous work using the NOS2−/− strain [18], we
observed increased numbers of cells in the lavage ﬂuid
(predominantly macrophages), which raised the question
of whether deletion of either of the other individual NOS
isoforms (NOS1 and NOS3) would have similar eﬀects
on the lavagable alveolar macrophage population. Because
we hypothesized that there would be an upregulation of
NOS2 in the constitutive knockouts, we expected to ﬁnd
no signiﬁcant increase in total lung cells in lavage ﬂuid
from the NOS1 and NOS3−/− animals exposed to ﬁltered
air. Our results were consistent with this hypothesis, as
we found similar BAL total cell counts in the constitutive
knockout strains and the C57Bl/6 mice. We conclude that
the deletion of individual NOS isoforms aﬀects NO output
by speciﬁc isoforms, but that the inability to normalize the
totallungNOconcentrationbyupregulatingNOS2resultsin
an increase in the recruitment of bone marrow-derived cells
as illustrated by an increase in the population of lavagable
macrophages only in the NOS2−/− mice.
In this study, NOS1−/− animals exposed to ﬁltered air
demonstrated a signiﬁcant change in lung compliance and
resistanceuponchallengewithmethacholine.Withincreased
NOS2 protein expression induced by OVA exposure, this
reactivity appeared to be diminished. We also saw a
signiﬁcant decrease in the respiratory system compliance
of NOS2−/− mice exposed to OVA compared to their
counterparts exposed to ﬁltered air. We interpret these
ﬁndings to suggest that changes in lung compliance in this
model directly reﬂect lung inﬂammation. Only the NOS1−/−
animals exposed to OVA demonstrated a signiﬁcant decrease
inlungcomplianceassociatedwithaconcomitantincreasein
lung resistance that reﬂects a bronchoconstrictive response.
These data suggest that NO from a speciﬁc enzyme source—
in this case from NOS1 in the subepithelial smooth muscle
and/or the epithelium—is responsible for the bronchodila-
tory properties of NO, but that the induction of NOS2 may
be suﬃcient to mitigate some aspects of AHR.
Samb et al. [31] and Maarsingh et al. [32]a t t r i b u t e
decreased NOS1 activity in pulmonary and tracheal smoothMediators of Inﬂammation 11
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Figure 9: Semiquantitative analysis of NOS2 staining intensity from NOS1−/− and NOS3−/− mouse strains exposed to ﬁltered air or OVA.
Immunohistochemical staining intensity and consistency of stain in the (a) airway epithelium, (b) smooth muscle of the airways and
vasculature, and (c) macrophage populations were scored on a scale of 0–10. Filtered air-exposed NOS1−/− and NOS3−/− mice displayed
uniform increases in NOS2 protein staining limited to the smooth muscle of airways and vasculature and the airway epithelium with no
change in macrophages. OVA-exposed NOS3−/− mice had a signiﬁcant reduction in NOS2 staining in the airway epithelium and smooth
muscle compared to their ﬁltered air-exposed counterparts. In contrast, OVA-exposed NOS1−/− mice maintained NOS2 protein staining
in the airway epithelium and a signiﬁcant increase in NOS2 in the macrophage population. Data are presented as mean values ± SEM
(n = 5-6); ∗ denotes P<. 05; ∗∗P<. 01 by ANOVA.
muscle after OVA challenge in guinea pigs to airway hyperre-
sponsiveness, and our data are consistent with these results.
De Sanctis et al. also examined changes in inﬂammatory
response in the NOS2−/− strain compared to the C57Bl/6
strainbutobservednosigniﬁcantincreaseintotalinﬂamma-
tory cell number [33]. Although our current and previous
observations appear to conﬂict with the ﬁndings of De
Sanctis, substantial variations in the exposure protocol may
have caused the diﬀering outcomes.
4.2. Regulation of NOS Isoforms and Consequences in Normal
Mice. NOS2 is capable of producing one thousand times
more NO than either of the constitutive isoforms [34]a n d
has multiple levels of regulation that are dependent upon
NO concentration [10, 35–41]. We hypothesized that under
normal noninﬂammatory conditions, deletion of the NOS1
or NOS3 gene would upregulate NOS2 protein expres-
sion. Knocking out individual constitutive NOS isoforms
would lower overall cellular NO concentration, resulting in12 Mediators of Inﬂammation
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Figure 10: PAS staining of 5μm-thick left lobe lung sections
from (a) C57Bl/6 ﬁltered air-exposed, (b) C57Bl/6 OVA-exposed,
(c) NOS1−/− OVA-exposed, and (d) NOS3−/− OVA-exposed mice.
Images were taken at 400× magniﬁcation.
increased NOS2 expression in order to maintain a minimal
total lung NO concentration. To test this hypothesis, we
measured lung NO and NOx concentrations, total airway
NOS protein content, and localized the expression of NOS2
protein in the four strains of mice (C57Bl/6 wild-type strain
and NOS1−/−,N O S 2 −/−,a n dN O S 3 −/−)e x p o s e dt oﬁ l t e r e d
air only.
The constitutive NOS knockout strains, NOS1−/− and
NOS3−/−, exposed to ﬁltered air showed signiﬁcant upregu-
lation of NOS2 protein expression compared to the C57Bl/6
wild-type control. As predicted, the NOS1−/− mice showed
no change in NOS3 expression and NOS3−/− mice showed
no change in NOS1 expression. These results support our
hypothesis that “NO homeostasis” is established by main-
taining a concentration of available total NO independent of
NOS isoform origin.
The NOS2−/− strain showed no signiﬁcant increase
in protein expression of either of the two constitutively
expressed NOS isoforms (NOS1 or NOS3). These results
indicate diﬀerent upstream regulatory mechanisms inducing
gene expression and potential translational control of the
two constitutive isoforms and indicate that the control of
constitutive NOS expression is not NO dependent. Thus,
we conclude that at baseline, NOS2 enzyme production can
be induced to maintain total lung NO homeostasis via a
mechanism that is capable of detecting decreased concentra-
tions of cellular NO and activating NOS2 expression. This
conclusion is in accordance with observations by Cook et al.
[10], who noted increased NOS2 expression and exhaled NO
concentrations in NOS3−/− mice.
Immunohistochemical analysis of whole lung sections
identiﬁed the cellular origins of NOS2 expression in the
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Figure 11: Percentage PAS positive cells present in the airway
epithelium from C57Bl/6, NOS1−/−, and NOS3−/− genotype mice
exposed to ﬁltered air or OVA. Filtered air-exposed mice displayed
an average of 0.45% PAS positive cells with no diﬀerence between
the three groups. OVA-exposed NOS1−/− mice had signiﬁcantly
fewer PAS positive-stained cells compared to the OVA-exposed
C57Bl/6. Data are presented as mean values±SEM; ∗∗ denotes P<
.01 by ANOVA.
ﬁltered air-exposed genotypes. Consistent with the western
blot results, the C57Bl/6 mice exposed to ﬁltered air showed
low expression of NOS2 protein, with only light staining
present in the smooth muscle and airway epithelium. In
contrast, both the NOS1−/− and NOS3−/− animals displayed
a signiﬁcant increase in NOS2 protein expression compared
to the C57Bl/6 mice by western blot analysis, and these
increases were limited to the airway epithelium and smooth
muscle tissue of the airway and vasculature (See Figures 8-
9). As the airway epithelium constitutively expresses both
NOS1 and NOS3 and is capable of upregulating NOS2
under inﬂammatory conditions, this result implies a tight
regulatory control of NO homeostasis in these particular
cell types. The smooth muscle tissue of the lung expresses
low levels of NOS2 protein in the C57Bl/6 mice and may
beneﬁt from vectorial production of NO derived from
adjacent epithelial and endothelial cells. As localized NO
concentrations decrease, NOS2 expression may be neces-
sary to maintain airway and vascular tone under basal
conditions.
4.3. Regulation of NOS Isoforms and Consequences in Mice
Exposed to Ovalbumin. Based upon recent studies by Vo et
al. [35] and Gobeil Jr. et al [17], which suggest that induction
of NOS2 gene expression by NF-κBi sd e p e n d e n tu p o n
NOS3 activity (Figure 8), we hypothesized that exposure
to ovalbumin would inhibit the increase in NOS2 protein
expression in the NOS3−/− mice.Mediators of Inﬂammation 13
We examined the upregulation of NOS2 in NOS1 and
NOS3−/− mice exposed to OVA to determine if the NO-
dependentmechanismtoinduceNOS2expressionisisoform
speciﬁc, that is, derived solely from the NOS3 isoform. If
the OVA-induced increase in NOS2 expression is driven
by the NOS3, we would expect no signiﬁcant increase in
NOS2 protein expression in the NOS3−/− animals while we
would expect an increase in NOS2 protein expression in
the NOS1−/− animals. In our study, the patterns of NOS2
expression in the OVA-exposed NOS1−/− and NOS3−/−
animals were consistent with this mechanism being NOS3
speciﬁc. In fact, we observed a surprising lack of NOS2
expression in the lungs of NOS3−/− animals overall by
immunohistochemistry.
Analysis of NOS2 expression in the NOS1−/− and
NOS3−/− lung compartments of mice exposed to OVA indi-
cated a signiﬁcant reduction of NOS2 in the airway epithe-
lium and smooth muscle compartments of the NOS3−/−
mice only, with NOS1−/− mice maintaining NOS2 protein
expression in both compartments, including upregulation
of macrophage NOS2 expression. While examining NOS2
protein content in the airway epithelium, we observed a
diﬀerence in the cellular population of the airway epithelium
between the diﬀerent mouse genotypes with exposure to
OVA that may have contributed to changes in NOS2
protein content. One limitation of our study is that we
used NOS gene knockout strains only and did not use
overexpressing mice to conﬁrm our ﬁndings. However, we
areencouragedbythecomplimentarydataofTenBroekeand
colleagues. They found that transgenic mice overexpressing
NOS3 increased NO production in the lungs, decreased
lung lavage inﬂammatory cell counts, and improved airway
hyperresponsiveness compared to littermate controls after
exposure to ovalbumin. One possible explanation for the
seeming overlap between Ten Broeke’s results and ours is the
interrelationship among the NOSs in the lung [19]. NOS3
expression appears to partly regulate NOS2 expression and
lung NO content. This suggests that important feedback
mechanisms to NOS3 regulate much of the measurable NO
that is produced in the lung in response to allergen.
The NOS 1−/− mice had a signiﬁcantly reduced number
of goblet cells present compared to the other three strains.
NOS1−/− mice exposed to OVA also had reduced airway
reactivity and airway inﬂammation compared to the other
strains, which may indicate roles for NOS1 in inﬂammatory
cell recruitment signaling and, potentially, airway epithelial
cell apoptosis. In addition to its eﬀects on airway hyper-
reactivity, NO has pro- and antiapoptotic eﬀects that are
concentration and cellular compartment dependent. The
NOS1isoformisalsolocalizedtothemitochondria(mtNOS)
and despite the ubiquitous nature of NO in the lung during
inﬂammation, deletion of the NOS1/mtNOS isoform may
contribute to the reversal of airway goblet cell metaplasia
seen in the other isoform knockout and C57Bl/6 strains
exposed to ovalbumin.
Although we were able to identify increased goblet cell
metaplasia in the airways of NOS3−/− mice exposed to
o v a l b u m i na sc o m p a r e dt oN O S 1 −/− mice, this change in
epithelial cell content did not account for the lack of NOS2
protein in the remaining intact epithelial cells. The cells that
were PAS-negative still comprised 50% of the airway cell
population. In addition, the lack of NOS2 protein in the
intact smooth muscle of the airways and vasculature of the
NOS3−/− mice was also noteworthy.
Though our hypothesis indicates that knockout of NOS3
resultsinaninabilitytosignalforincreasedNOS2expression
upon allergen exposure, an alternative explanation exists
for these results that we could not address within the
scope of our studies in intact animals. NF-κB-dependent
transcription can also be aﬀected by nitrosation of the Rel
and p50 components of the active NF-κB complex. In high
NO environments such as cell culture medium with high
concentrations of NO donor compounds added, cysteine
residues of both p65 and p50 have been shown to be
nitrosated, resulting in reduced DNA-binding capacity [35,
39–41]( Figure 9). Increased NO production by NOS2 under
inﬂammatory conditions may be suﬃcient to nitrosate these
residues resulting in the activation of this negative feedback
loop.
4.4. Potential Alternative Sources of NO in the Lungs of the
Mice Exposed to Ovalbumin. Despite the lack of NOS2 in
the lungs of NOS3−/− animals exposed to OVA, increases
in BAL NOx concentrations in the NOS3−/− mice may
indicate an accumulation of NO metabolites in the lung
from another source. There is increasing evidence suggesting
that nitrite serves as a bioavailable pool of NO to act as a
vasodilator, as deoxyhemoglobin may have nitrite reductase
activity, promoting this conversion [6]. While we did not
measure the arterial oxygen saturation of our mice during
this experiment, it is possible that the ventilation-perfusion
mismatching as a result of dense inﬂammatory inﬁltrate
and/or methacholine challenge could lead to regional hypox-
emia and have an eﬀect on NOx to NO conversion. However,
we did not see changes in either NO or NOx concentrations
in NOS2−/− animals after exposure to OVA that would
be consistent with this pathway. In addition, it has been
theorized that alterations in the pH of the airway lining ﬂuid
as a result of inﬂammatory cell inﬂux and oxidative damage
may result in nitrite conversion to NO. Both the NOS3−/−
andNOS2−/− micehadmoreinﬂammatorycellsintheirBAL
ﬂuid but their exhaled NO concentrations were relatively
unaﬀected.
5. Conclusions
Examination of individual NOS isoform knockout and
C56Bl/6 strains exposed to ﬁltered air supports the hypoth-
esis that there is an NOS-dependent mechanism in the cell
that maintains a “baseline” NO production in both airway
epithelium and airway and vascular smooth muscle and
is unable to distinguish between NOS isoforms of origin.
Under inﬂammatory conditions, the expression of the NOS2
isoform is essential for reducing lung inﬂammation and may
also contribute to the normalization of airway reactivity.
NOS3 isoform activity is essential for the upregulation of
NOS2inresponsetoovalbuminexposure.Incontrast,NOS214 Mediators of Inﬂammation
can be expressed independently of NOS1 activity in the
inﬂamed lung, but NOS1 activity contributes to goblet cell
metaplasia in the airways of ovalbumin-exposed animals.
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